Hyperliquid Strategies Inc. reported a net loss of $165.4 million for the nine months ending March 31, according to its latest Nasdaq filing. The company said the result was driven mainly by $64 million in net unrealized losses on its HYPE token holdings, a $35.6 million write-off tied to the Sonnet BioTherapeutics acquisition, and a $60.5 million increase in deferred tax expense.
The loss is largely an accounting outcome reflecting price volatility in HYPE before March 31, combined with the one-time Sonnet charge and tax adjustments.
Quarter flips to $152.5 million profit on digital asset gains
In sharp contrast, the company reported a $152.5 million net profit for the three months ending March 31. That result was almost entirely powered by $198.4 million in unrealized gains on its digital asset portfolio, underscoring the company’s direct exposure to HYPE price movements.
For the quarter, staking activities generated $2.6 million in revenue and interest income totaled $1 million. Operating expenses were $7.2 million over the same period.
HYPE token appreciation boosts treasury value
Hyperliquid Strategies holds roughly 20 million HYPE tokens. Since its formation in December 2025, it has committed about $216 million to acquire around 7.3 million tokens.
The firm used a quarter-end HYPE token price of $36.60 for its March 31 report. By May 6, 2026, HYPE was trading near $44.05, implying more than 20% appreciation after the close of the reporting period. At that price, HYPE’s market capitalization stood at about $10.5 billion, placing it among the top 15 digital assets globally and increasing the implied value of Hyperliquid Strategies’ treasury.
Shift from biotech to digital asset treasury manager
Hyperliquid Strategies previously merged with Sonnet BioTherapeutics, using the transaction to exit most of its legacy biotechnology activities and reposition as a public company focused on managing and expanding its HYPE token treasury. Its strategy centers on staking and yield-oriented approaches within the Hyperliquid decentralized finance ecosystem.
Chief Executive Officer Schamis said in the filing that the firm scaled its HYPE treasury, completed the sale of most remaining biotech assets during the quarter, and expanded its participation in the network.
Validator partnership aims to grow staking revenue
To deepen its role in decentralized finance, Hyperliquid Strategies has established a validator partnership with Unit, also referenced as Unit Labs. The joint validator is expected to go live around May 11, 2026.
The venture is intended to put the company’s large HYPE treasury to work securing the Hyperliquid network, with the goal of raising staking revenue beyond the $2.6 million recorded in the latest quarter.
Network activity accelerates across new products
The underlying Hyperliquid network is in a period of rapid growth. Following a protocol upgrade, trading volumes in real-world asset products such as oil and gold have surged, driving open interest in these new markets to $2.3 billion in April.
In addition, the launch of Hyperliquid’s own prediction markets has drawn immediate activity. Trading volume reached 6.05 million contracts in the first 24 hours, signaling early traction in a competitive segment.
Token holdings and share buybacks reinforce conviction
By the end of April, Hyperliquid Strategies had expanded its HYPE holdings to 20 million tokens. The company also deployed $10.5 million to repurchase about 3 million shares of its common stock, PURR, at an average price of $3.42.
It ended the nine-month period with $103 million in cash, earmarked for further treasury additions, share repurchases, and general operations. Taken together, the growing HYPE position and active buyback program point to a strong internal conviction in both the network’s native token and the company’s equity.
Large HYPE unlock seen as manageable
A scheduled unlock of 9.92 million HYPE tokens for core contributors took place on May 6, raising concerns about potential selling pressure. However, the company and market observers point to historical unlock patterns, where claim rates have remained low.
For the May 6 event, estimates suggested that only about 422,000 tokens, or less than 5% of the unlocked amount, would actually be claimed and have the potential to move into circulation.
Analysts maintain upbeat view on PURR stock
Equity analysts have responded positively to the company’s strategic direction and its alignment with the Hyperliquid ecosystem. Coverage on PURR currently reflects a “strong buy” consensus, with an average 12-month price target of $8.15 per share.
PURR has returned about 94% year-to-date and is trading near its 52-week high, mirroring rising optimism around HYPE, the broader network expansion, and Hyperliquid Strategies’ treasury-driven business model.
Curious how volatility shapes results like Hyperliquid’s? Learn to manage risk with Toobit’s crypto risk management strategies today.
Disclaimer: The content on this page is provided for general informational purposes only and does not represent the views or financial advice of Toobit. We make no guarantees regarding the accuracy or completeness of this information and shall not be held liable for any errors, omissions, or outcomes resulting from its use. Investing in digital assets involves risk; users should independently evaluate their financial situation and the risks involved. For further details, please consult our Terms of Service and Risk Disclosure.
